China's Compulsory Licenses — A Danger To Pharma Patents

Law360, New York (October 1, 2012, 1:26 PM EDT) -- The following issues are addressed in this article:

where to apply for compulsory license in China; how to select patents for compulsory license; what to say in compulsory license application; how much time the patent owner has to rebut; and whether a compulsory license will be stayed during appeal.

On March 15, 2012, the State Intellectual Property Office of China (SIPO) released a new version of compulsory patent license rules. The rules went into effect on May 1, 2012, and now provide a road map for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.